Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

Subjects:

Change in cardio-metabolic risk factors after cafeteria intervention (n = 257). by Archana Shrestha (3641959)

Subjects:

Data_Sheet_1_Risk of psychological distress by decrease in economic activity, gender, and age due to COVID-19: A multinational study.PDF by Minji Kim (1722313)

“…</p>Discussion<p>Psychological distress due to COVID-19 revealed a significant association with decrease in economic activity, women, and younger age. …”

Summary table of statistical values (Chi sq. and p-value) for Generalised Additive Models examining relationships between seasonal roadkill patterns and two abiotic variables: Mean... by Sarah Raymond (11529759)

Subjects:

Mean age of patients submitting stool samples per study site. by Amete Mihret Teshale (12072758)

Subjects:

Top 10 significant functional annotations of up-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance according to the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

Top 10 significant functional annotations of down-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

A total of 700 DEGs. by Wei He (131453)

“…Compared with normal tissues, AAD tissues exhibited a significant decrease in CD8 T cells and an increase in NK cells and macrophages.…”

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Multivariable logistic regression analysis for risk factors associated with BLL > 5 μg/dL (n = 3804). by Chun-Wan Fang (635764)

Subjects:

Means and Cronbach’s alphas for 5C and VAX-measured vaccination attitudes over 12 months. by Allyson J. Gallant (9382396)

Subjects:

Face-to-face angle (yaw rotation [deg]). by Atsushi Nakazawa (15892700)

PRISMA flow diagram. by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus control on LDL-cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Treatment and outcome characteristics. by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2 mg on serum creatinine (mg/dL). by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus control on total cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on LDL-cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Characteristics of included studies and subjects. by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on total cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects: